The European Brain Research Area: Building a Brain Health Partnership (Organised by EBRA)
July 11 | 12:00 - 12:45
The European Brain Research Area (EBRA) will organise a social event in the context of the FENS Forum 2022. Organised by FENS in partnership with the French Neuroscience Society, the FENS Forum 2022 will take place on 9-13 July 2022 in Paris, France.
Brain research is a rapidly evolving field and increasingly at the forefront of science. The EU and its Member States have made considerable investment in brain research leading to a significant increase of initiatives in this area. Although these initiatives have generated considerable amounts of knowledge and innovative approaches, the translation into new health interventions is hindered by the complexity of the challenge and by excessive fragmentation of efforts. Effective and efficient collaboration among the various initiatives is often identified as a key success factor to achieve the full impact of brain research. The European Brain Research Area project therefore aims to bring together the various stakeholders and major brain research initiatives, at European level and beyond, creating the conditions for real and effective cross fertilisation, dialogue, building consensus and exploiting research potential.
During this special session, the EBRA consortium — consisting of the European Brain Council, the ERANET-NEURON, the EU Joint Programme for Neurodegenerative Disease Research and the Human Brain Project — will highlight the importance of shaping the future of European and globally coordinated neuroscience. In this perspective, the Shared European Brain Research Agenda (SEBRA) will be presented, and discussion will focus on the building of a new partnership on brain health.
Prof. Monica Di Luca (Coordinator, European Brain Research Area)
Prof. Marlies Dorlöchter (Coordinator, ERA-NET NEURON)
Prof. Philippe Amouyel (Chair, EU Joint Programme for Neurodegenerative Disease Research)
Pawel Swieboda (Director General, Human Brain Project and CEO, EBRAINS)